Clinical Trial Update: A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer [Phase 2]

View source ↗

Summary

This update presents results from a Phase 2 study of recurrent or metastatic squamous cell head and neck cancer sponsored by Eli Lilly; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Eli Lilly and Company | Conditions: Head and Neck Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2014-05-19